L-alanyl-gamma-D-glutamyl-meso-diaminopimelic acid

Term ID

CHEBI:61564

Synonyms

L-Ala-gamma-D-Glu-mDAP
L-Ala-gamma-D-Glu-meso-Dap
L-ala-gamma-D-Glu-meso-diaminopimelic acid
L-alanyl-N-[(1R,5S)-5-amino-1,5-dicarboxypentyl]-D-glutamine
Tri-DAP

Definition

A tripeptide comprising L-alanyl, γ-D-glutamyl and meso-diaminopimelic acid residues in a linear sequence. It is a breakdown product of bacterial peptidoglycan and a NOD1 agonist.

References

metacyc.compound:L-ALA-GAMMA-D-GLU-DAP
pubmed:20558765
pubmed:23328697
pubmed:25253572
pubmed:28962692
pubmed:29224352
pubmed:30851423
pubmed:34780976
pubmed:35990669
pubmed:36043447
reaxys:15589879

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from L-alanyl-gamma-D-glutamyl-meso-diaminopimelic acid

Phenotype where environments contain L-alanyl-gamma-D-glutamyl-meso-diaminopimelic acid

Phenotype modified by environments containing L-alanyl-gamma-D-glutamyl-meso-diaminopimelic acid

Phenotype affecting L-alanyl-gamma-D-glutamyl-meso-diaminopimelic acid

Human Disease Model